Stock Scorecard



Stock Summary for Tenaya Therapeutics Inc (TNYA) - $4.38 as of 4/25/2024 2:46:38 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TNYA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TNYA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TNYA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for TNYA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for TNYA

Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight 4/9/2024 9:41:00 PM
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday - Alta Equipment Group ( NYSE:ALTG ) , Despegar.com ( NYSE:DESP ) , Blend Labs ( NYSE:BLND ) 3/15/2024 2:25:00 PM
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences 2/27/2024 9:30:00 PM
Should You Buy Tenaya Therapeutics, Inc. ( TNYA ) After Golden Cross? 2/26/2024 2:55:00 PM
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications 2/26/2024 1:30:00 PM
Wall Street Analysts Think Tenaya Therapeutics, Inc. ( TNYA ) Could Surge 273.1%: Read This Before Placing a Bet 2/9/2024 2:55:00 PM
Tenaya Therapeutics Announces Pricing of Underwritten Offering - Tenaya Therapeutics ( NASDAQ:TNYA ) 2/8/2024 1:00:00 PM
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer 2/7/2024 1:05:00 PM
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer - Terns Pharma ( NASDAQ:TERN ) 2/7/2024 1:05:00 PM
Tenaya Therapeutics, Inc. ( TNYA ) Upgraded to Strong Buy: Here's Why 1/26/2024 5:00:00 PM

Financial Details for TNYA

Company Overview

Ticker TNYA
Company Name Tenaya Therapeutics Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 12/31/2023
Next Earnings Date 5/8/2024

Stock Price History

Last Day Price 4.38
Last Day Price Updated 4/25/2024 2:46:38 PM EST
Last Day Volume 321,384
Average Daily Volume 457,522
52-Week High 8.09
52-Week Low 1.66
Last Price to 52 Week Low 163.86%

Valuation Measures

Trailing PE N/A
Industry PE 61.03
Sector PE 61.73
5-Year Average PE -0.98
Free Cash Flow Ratio 3.29
Industry Free Cash Flow Ratio 18.94
Sector Free Cash Flow Ratio 30.74
Current Ratio Most Recent Quarter 4.91
Total Cash Per Share 1.33
Book Value Per Share Most Recent Quarter 2.04
Price to Book Ratio 2.50
Industry Price to Book Ratio 7.50
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 9.51
Sector Price to Sales Ratio Twelve Trailing Months 5.16

Share Statistics

Total Shares Outstanding 78,518,000
Market Capitalization 343,908,840
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -0.32%
Reported EPS 12 Trailing Months -1.68
Reported EPS Past Year 0.00
Reported EPS Prior Year -1.67
Net Income Twelve Trailing Months -124,100,000
Net Income Past Year -124,100,000
Net Income Prior Year -123,700,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 104,600,000
Total Cash Past Year 104,600,000
Total Cash Prior Year 204,200,000
Net Cash Position Most Recent Quarter 104,600,000
Net Cash Position Past Year 104,600,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 139,424,000
Total Stockholder Equity Prior Year 243,376,000
Total Stockholder Equity Most Recent Quarter 139,424,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.21
MACD Signal -0.19
20-Day Bollinger Lower Band 1.73
20-Day Bollinger Middle Band 4.38
20-Day Bollinger Upper Band 7.03
Beta 2.61
RSI 41.52
50-Day SMA 4.33
200-Day SMA 0.00

System

Modified 4/25/2024 1:18:27 PM EST